Metraipolis › archive › dc_e35f0bd67378

Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets — Europe PMC PMID:41789342

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41789342
DOI
10.31083/rcm43846
License (as archived)
solo-consultazione
Archived
2026-11-05T23:44:23.278Z
SHA-256 of the archived text
80d522a10a06498cfa2379d14bf342e01f7e4e1cd0e6b8080fd1abeb20ad76cb
Stable URL of this page
https://metraipolis.com/documento/dc_e35f0bd67378

How to cite

Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets — Europe PMC PMID:41789342 — Europe PMC (en), https://europepmc.org/article/MED/41789342 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e35f0bd67378 (Metraipolis archive dc_e35f0bd67378, sha256 80d522a10a06498cfa2379d14bf342e01f7e4e1cd0e6b8080fd1abeb20ad76cb)
BibTeX
@misc{dce35f0bd67378,
  title = {Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets — Europe PMC PMID:41789342},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41789342},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e35f0bd67378; sha256 80d522a10a06498cfa2379d14bf342e01f7e4e1cd0e6b8080fd1abeb20ad76cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41789342. Agents can read the archived copy with the MCP tool read_document.